The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.

"The beauty of connected TV is that we can run one creative on Cartoon Network and another on the Golf Channel," says Dutch ...

A mass influx of buzzy ads and even Super Bowl commercials for these products by trendy telehealth companies like Hims & Hers and Ro have pitched ... weight-loss agents—starting with Wegovy in June ...

Dream11, known for its creative and collaborative ads, has once again nailed it with a hilarious video featuring some of the biggest stars, including Ranbir Kapoor, Aamir Khan, Rohit Sharma ...

President Donald Trump beamed from in front of and inside a Tesla Model S on Tuesday, telling reporters gathered on the White House driveway that the electric vehicle was "beautiful." The bit of ...

(This section is what permits Hims & Hers to produce otherwise patent-protected GLP-1 drugs while the supply of such drugs is in deficit.) As regards semaglutide, FDA says compounders such as Hims ...

By Erika Wheless - 1 hour 58 min ago By Berkeley Bethune - 2 hours 33 min ago By Tim Nudd - 2 hours 35 min ago By Jack Neff - 2 hours 43 min ago 5 hours 43 min ago By Ad Age Staff - 9 months ago ...

The Grammy-nominated artist has partnered with Zevia for a new commercial which dropped on Monday, March 20, and he's rocking a look that no one saw coming: cut-off Daisy Dukes. The commercial ...

The telehealth company had acquired Apostrophe in 2021 for $190 million to expand its skincare offerings. However, HIMS is now integrating Apostrophe’s services into its core Hims & Hers ...

The Creative Circle Best of the Year awards, which honour South Africa’s best advertising from 2024, took place recently in Johannesburg, and amongst the winners were Accidental Art for Lexus ...

Shares of HIMS stock opened at $36.01 on Thursday. Hims & Hers Health has a 12-month low of $11.20 and a 12-month high of $72.98. The firm has a market capitalization of $8.00 billion, a price-to ...

Hims & Hers Health (NYSE:HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A message at the top of Apostrophe's website says, "Apostrophe is being ...